International Scientific Publications
© 2007-2026 Science Events Ltd
Terms of Use  ·  Privacy Policy
Language English French Polish Romanian Bulgarian
Conference room
Materials, Methods & Technologies 2026, 28th International Conference
13-16 August, Burgas, Bulgaria
Call for Papers

Materials, Methods & Technologies, Volume 5, 2011

IMAGING STUDIES OF TETRA-SULPHONATED PORPHYRIN IN K562 HUMAN CHRONIC MYELOID LEUKEMIA CELLS DURING PHOTODYNAMIC THERAPY
Simona-Florentina Pop, Monica Neagu, Carolina Constantin, Rodica-Mariana Ion
Pages: 42-50
Published: 1 Jan 2011
Views: 89
Abstract: Non-invasive monitoring of molecular targets isparticularly relevant to photodynamic therapy (PDT), including the delivery of photosensitizer in the treatment site and monitoring of molecular and physiological changes following treatment. Photodynamic therapy consists of the uptake of a photosensitizing dye by tumor tissue and subsequent irradiation of the tumor with light of an appropriate wavelength matched to the absorption spectrum of the photosensitizing dye. Singlet oxygen is accepted as the main mediator of photocytotoxicity in photodynamic therapy, causing irreversible cell damage by oxidation and degradation of (intra)cellular biomembrane structures, but with minimal systemic toxicity. This report presents a study of the in vitro non-uniform intracellular distribution of 5, 10, 15, 20 -tetra (4-sulfophenyl) porphyrin (TS PP) on K562 human chronic 4 myeloid leukemia cell line.
Keywords: ts pp, k562 human chronic myeloid leukemia cell line, optical imaging, photodynamic
Cite this article: Simona-Florentina Pop, Monica Neagu, Carolina Constantin, Rodica-Mariana Ion. IMAGING STUDIES OF TETRA-SULPHONATED PORPHYRIN IN K562 HUMAN CHRONIC MYELOID LEUKEMIA CELLS DURING PHOTODYNAMIC THERAPY. Journal of International Scientific Publications: Materials, Methods & Technologies 5, 42-50 (2011). https://www.scientific-publications.net/en/article/1003318/
Back to the contents of the volume

Submit Feedback

We value your input! Use this form to report any concerns or provide feedback on our published articles. All submissions will be kept confidential.

By using this site you agree to our Privacy Policy and Terms of Use. We use cookies, including for analytics, personalisation, and ads.